Researchers Discover NTRK1 Fusions as Potential PGx Marker in Lung Cancer | GenomeWeb

Originally published Oct. 29.

In a preliminary study, researchers have discovered that rearrangements in a gene called NTRK1 may drive lung cancer in a minority of patients. If confirmed in a larger trial, this marker will join the ever growing list of genetic aberrations that doctors can use to reclassify the lung cancer population into smaller and smaller patient subsets based on the unique molecular characteristics of their illness.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.